Absence of inducible costimulator (ICOS) on alloreactive T cells reduces graft-versus-host-disease while leaving graft-versus-tumor activity intact.

被引：0
|
作者：
Hubbard, VM [1 ]
Eng, JM [1 ]
Tjoe, KH [1 ]
Ramirez-Montagut, T [1 ]
Muriglan, SJ [1 ]
Kochman, AA [1 ]
Terwey, TH [1 ]
Schiro, R [1 ]
Alpdogan, O [1 ]
van den Brink, MRM [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
591
引用
收藏
页码：171A / 171A
页数：1
相关论文
共 50 条
  • [1] Absence of inducible costimulator on alloreactive T cells reduces graft-versus-host-disease while leaving graft-versus-tumor activity intact
    Tjoe, KH
    Eng, JM
    Alpdogan, O
    Muriglan, SJ
    Hubbard, VM
    Kochman, AA
    Schiro, R
    van den Brink, MRM
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 50 - 51
  • [2] Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviation
    Hubbard, VM
    Eng, JM
    Ramirez-Montagut, T
    Tjoe, KH
    Muriglan, SJ
    Kochman, AA
    Terwey, TH
    Willis, LM
    Schiro, R
    Heller, G
    Murphy, GF
    Liu, C
    Alpdogan, O
    van den Brink, MRM
    BLOOD, 2005, 106 (09) : 3285 - 3292
  • [3] B7-/- donor T cells cause less graft-versus-host disease while preserving graft-versus-tumor activity
    Waldman, ED
    Alpdogan, O
    Petrovic, A
    Eng, JM
    Hubbard, V
    Kochman, A
    Muriglan, S
    van den Brink, MRM
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 48 - 49
  • [4] Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviation (vol 106, pg 3285, 2005)
    Hubbard
    BLOOD, 2006, 107 (01) : 38 - 38
  • [5] Absence of donor T-cell-derived soluble TNF decreases graft-versus-host disease without impairing graft-versus-tumor activity
    Borsotti, Chiara
    Franklin, Anna R. K.
    Lu, Sydney X.
    Kim, Theo D.
    Smith, Odette M.
    Suh, David
    King, Chris G.
    Chow, Andrew
    Liu, Chen
    Alpdogan, Onder
    van den Brink, Marcel R. M.
    BLOOD, 2007, 110 (02) : 783 - 786
  • [6] The complex and central role of interferon-γ in graft-versus-host disease and graft-versus-tumor activity
    Wang, Hui
    Yang, Yong-Guang
    IMMUNOLOGICAL REVIEWS, 2014, 258 (01) : 30 - 44
  • [7] Ceacam1 Separates Graft-versus-Host-Disease from Graft-versus-Tumor Activity after Experimental Allogeneic Bone Marrow Transplantation
    Lu, Sydney X.
    Kappel, Lucy W.
    Charbonneau-Allard, Anne-Marie
    Atallah, Renee
    Holland, Amanda M.
    Turbide, Claire
    Hubbard, Vanessa M.
    Rotolo, Jimmy A.
    Smith, Marsinay
    Suh, David
    King, Christopher
    Rao, Uttam K.
    Yim, Nury
    Bautista, Johanne L.
    Jenq, Robert R.
    Penack, Olaf
    Na, Il-Kang
    Liu, Chen
    Murphy, George
    Alpdogan, Onder
    Blumberg, Richard S.
    Macian, Fernando
    Holmes, Kathryn V.
    Beauchemin, Nicole
    van den Brink, Marcel R. M.
    PLOS ONE, 2011, 6 (07):
  • [8] Graft-versus-tumor (GvT) effects in the absence of alloantigens on tumor cells crucially depend on graft-versus-host disease (GvHD) intensity.
    Albring, JC
    Stelljes, M
    Berdel, WE
    Kienast, J
    BLOOD, 2005, 106 (11) : 379A - 379A
  • [9] CD103 Deficiency Prevents Graft-versus-Host Disease but Spares Graft-versus-Tumor Effects Mediated by Alloreactive CD8 T Cells
    Liu, Kechang
    Anthony, Bryan A.
    Yearsly, Martha M.
    Hamadani, Mehdi
    Gaughan, Alice
    Wang, Jiao-Jing
    Devine, Steven M.
    Hadley, Gregg A.
    PLOS ONE, 2011, 6 (07):
  • [10] Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM)
    Taylor, PA
    Panoskaltsis-Mortari, A
    Freeman, GJ
    Sharpe, AH
    Noelle, RJ
    Rudensky, AY
    Mak, TW
    Serody, JS
    Blazar, BR
    BLOOD, 2005, 105 (08) : 3372 - 3380
12345